BrightSpring Health Services (BTSG) Competitors

$11.06
+0.40 (+3.75%)
(As of 05/2/2024 ET)

BTSG vs. ADUS, AHCO, AMED, EHAB, OPCH, GPCR, FUSN, NEO, AMRX, and TWST

Should you be buying BrightSpring Health Services stock or one of its competitors? The main competitors of BrightSpring Health Services include Addus HomeCare (ADUS), AdaptHealth (AHCO), Amedisys (AMED), Enhabit (EHAB), Option Care Health (OPCH), Structure Therapeutics (GPCR), Fusion Pharmaceuticals (FUSN), NeoGenomics (NEO), Amneal Pharmaceuticals (AMRX), and Twist Bioscience (TWST). These companies are all part of the "medical" sector.

BrightSpring Health Services vs.

BrightSpring Health Services (NASDAQ:BTSG) and Addus HomeCare (NASDAQ:ADUS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Addus HomeCare has lower revenue, but higher earnings than BrightSpring Health Services.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$8.83B0.21-$154.60MN/AN/A
Addus HomeCare$1.06B1.49$62.52M$3.8425.18

Addus HomeCare received 280 more outperform votes than BrightSpring Health Services when rated by MarketBeat users. However, 87.50% of users gave BrightSpring Health Services an outperform vote while only 66.82% of users gave Addus HomeCare an outperform vote.

CompanyUnderperformOutperform
BrightSpring Health ServicesOutperform Votes
14
87.50%
Underperform Votes
2
12.50%
Addus HomeCareOutperform Votes
294
66.82%
Underperform Votes
146
33.18%

BrightSpring Health Services presently has a consensus price target of $15.75, suggesting a potential upside of 48.44%. Addus HomeCare has a consensus price target of $103.00, suggesting a potential upside of 6.42%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities analysts clearly believe BrightSpring Health Services is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
3.00
Addus HomeCare
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71

Addus HomeCare has a net margin of 5.91% compared to BrightSpring Health Services' net margin of 0.00%. Addus HomeCare's return on equity of 9.70% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health ServicesN/A N/A N/A
Addus HomeCare 5.91%9.70%6.70%

In the previous week, BrightSpring Health Services had 4 more articles in the media than Addus HomeCare. MarketBeat recorded 8 mentions for BrightSpring Health Services and 4 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.84 beat BrightSpring Health Services' score of -0.02 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Addus HomeCare
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

95.4% of Addus HomeCare shares are held by institutional investors. 4.4% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Addus HomeCare beats BrightSpring Health Services on 9 of the 15 factors compared between the two stocks.

Get BrightSpring Health Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTSG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTSG vs. The Competition

MetricBrightSpring Health ServicesHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.85B$2.66B$4.92B$7.51B
Dividend YieldN/A0.28%2.87%3.98%
P/E RatioN/A14.02182.5514.11
Price / Sales0.211.262,503.7087.24
Price / Cash26.6615.2846.8735.59
Price / Book3.163.204.804.28
Net Income-$154.60M-$7.39M$103.26M$214.33M
7 Day Performance3.94%2.63%3.20%1.47%
1 Month Performance2.37%-4.43%-3.82%-3.62%
1 Year PerformanceN/A25.02%6.07%8.45%

BrightSpring Health Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.244 of 5 stars
$94.54
+3.1%
$103.00
+8.9%
+10.8%$1.53B$1.06B24.6234,846Upcoming Earnings
AHCO
AdaptHealth
3.5866 of 5 stars
$9.96
+4.0%
$12.10
+21.5%
-14.4%$1.32B$3.20B-1.8810,700Upcoming Earnings
Gap Up
AMED
Amedisys
2.7167 of 5 stars
$91.79
+0.7%
$97.50
+6.2%
+14.7%$3.00B$2.24B-143.4219,000Analyst Revision
EHAB
Enhabit
1.2828 of 5 stars
$10.03
+1.6%
$12.08
+20.5%
-17.9%$503.11M$1.05B-6.1910,800Upcoming Earnings
News Coverage
Positive News
OPCH
Option Care Health
4.9765 of 5 stars
$29.61
+1.1%
$38.13
+28.8%
-8.1%$5.15B$4.30B19.487,802Positive News
GPCR
Structure Therapeutics
1.6677 of 5 stars
$38.94
-0.1%
$85.71
+120.1%
+60.5%$1.81BN/A-46.9293Upcoming Earnings
Short Interest ↑
FUSN
Fusion Pharmaceuticals
0.9231 of 5 stars
$21.42
+0.1%
$20.25
-5.5%
+422.4%$1.82B$2.07M-14.57101Upcoming Earnings
Short Interest ↓
NEO
NeoGenomics
2.8621 of 5 stars
$14.14
+2.1%
$19.50
+37.9%
-5.2%$1.81B$591.64M-20.202,100Analyst Report
News Coverage
AMRX
Amneal Pharmaceuticals
1.7407 of 5 stars
$5.87
-0.5%
$7.31
+24.6%
+229.0%$1.80B$2.39B-18.937,700Upcoming Earnings
Short Interest ↑
TWST
Twist Bioscience
3.032 of 5 stars
$31.54
+1.5%
$36.40
+15.4%
+158.4%$1.82B$245.11M-8.74919News Coverage

Related Companies and Tools

This page (NASDAQ:BTSG) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners